Related Experiment Video
Updated: Jan 3, 2026

Glutamate and Hypoxia as a Stress Model for the Isolated Perfused Vertebrate Retina
Published on: March 22, 2015
The Role of the P2X7 Receptor in Ocular Stresses: A Potential Therapeutic Target
Mélody Dutot1,2, Elodie Olivier1, Anaïs Wakx1
1UMR 8638 CNRS COMETE, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006 Paris, France.
Abstract:
The P2X7 receptor is expressed in both anterior and posterior segments of the eyeball. In the ocular surface, the P2X7 receptor is activated in case of external aggressions: preservatives and surfactants induce the activation of P2X7 receptors, leading to either apoptosis, inflammation, or cell proliferation. In the retina, the key endogenous actors of age-related macular degeneration, diabetic retinopathy, and glaucoma act through P2X7 receptors' activation and/or upregulation of P2X7 receptors' expression. Different therapeutic strategies aimed at the P2X7 receptor exist. P2X7 receptor antagonists, such as divalent cations and Brilliant Blue G (BBG) could be used to target either the ocular surface or the retina, as long as polyunsaturated fatty acids may exert their effects through the disruption of plasma membrane lipid rafts or saffron that reduces the response evoked by P2X7 receptor stimulation. Treatments against P2X7 receptor activation are proposed by using either eye drops or food supplements.
Insights
The P2X7 receptor plays a role in eye health, influencing ocular surface responses and retinal diseases like macular degeneration. Therapies targeting this receptor, using eye drops or supplements, show promise for various eye conditions.
Area of Science:
- Ophthalmology
- Cell Biology
- Pharmacology
Background:
- The P2X7 receptor is present in the anterior and posterior segments of the eye.
- External aggressors like preservatives and surfactants activate ocular surface P2X7 receptors, potentially causing apoptosis, inflammation, or proliferation.
- Retinal P2X7 receptor activation or upregulation is implicated in age-related macular degeneration, diabetic retinopathy, and glaucoma.
Purpose of the Study:
- To explore the role of the P2X7 receptor in ocular health and disease.
- To review therapeutic strategies targeting P2X7 receptor activation in the eye.
Main Methods:
- Review of existing literature on P2X7 receptor function in ocular tissues.
- Analysis of therapeutic agents and approaches targeting the P2X7 receptor.
Main Results:
- P2X7 receptor activation by external stimuli affects ocular surface cells.
- P2X7 receptor is a key mediator in major retinal diseases.
- Several therapeutic strategies, including antagonists like divalent cations and Brilliant Blue G (BBG), are being investigated.
Conclusions:
- P2X7 receptor antagonists and modulators offer potential therapeutic avenues for ocular surface and retinal diseases.
- Treatments may involve topical eye drops or oral supplements targeting P2X7 receptor pathways.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Accessory Structures of the Eye

